Related Experiment Video
Updated: Oct 28, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Regulatory variants in TCF7L2 are associated with thoracic aortic aneurysm
Tanmoy Roychowdhury1, Haocheng Lu1, Whitney E Hornsby1
1Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Genetic variants in TCF7L2 are linked to thoracic aortic aneurysm (TAA) risk, distinct from their role in type 2 diabetes. Increased TCF7L2 expression promotes cell death, contributing to TAA development.
Area of Science:
- Genetics
- Cardiovascular Disease
- Molecular Biology
Background:
- Thoracic aortic aneurysm (TAA) is a heritable condition involving aortic dilation, with unknown genetic origins for most cases.
- Previous research suggested common variants in FBN1 may influence TAA risk.
- Understanding the genetic basis of TAA is crucial for identifying at-risk individuals and developing targeted therapies.
Purpose of the Study:
- To identify novel genetic risk factors for thoracic aortic aneurysm (TAA).
- To investigate the functional role of identified genetic associations in TAA pathogenesis.
Main Methods:
- Genome-wide association study (GWAS) in 1,351 TAA cases and 18,295 controls.
- Replication and meta-analysis across four independent cohorts.
- In vitro studies to explore the functional impact of TCF7L2 expression.
Main Results:
- A genome-wide significant association between TAA and variants in the third intron of TCF7L2 was identified.
- The TCF7L2 locus shows an opposite direction of effect for TAA compared to type 2 diabetes.
- Genetic association colocalizes with an aortic expression quantitative trait locus (eQTL) for TCF7L2, suggesting higher expression increases TAA risk.
Conclusions:
- Common variants in TCF7L2 represent a significant genetic risk factor for thoracic aortic aneurysm (TAA).
- Upregulation of TCF7L2 promotes vascular smooth muscle cell apoptosis via BCL2 repression, a key mechanism in TAA.
- TCF7L2 plays a distinct role in TAA pathogenesis compared to its established role in type 2 diabetes.
Related Concept Videos
Thoracic Aorta
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Master Transcription Regulators
Aneurysm I: Introduction
Cis-regulatory Sequences

